Have Your Oncology Trials Got Their Running Shoes?
Add bookmark
Have Your Oncology Trials Got Their Running Shoes?
Add bookmark
Oncology is the largest investment area for the pharmaceutical industry, as a result there is a great deal of competition between key players and emphasis on speeding time to market. Benedikte Thunes Akre, Scientific Advisor - Oncology at Bristol Myers-Squibb, spoke to Andrea Charles from Pharma IQ, about the factors critical to the success of clinical development programs and how to overcome the key challenges in optimal clinical development. Akre also shares her insights on developing a strategic approach to partnering and collaborating with CROs and how to develop an effective working relationship with your partner to ensure efficiency and speed time to market.
[inlinead]
Tags:
Benedikte Thunes Akre
Bristol Myers-Squibb
oncology trials
Clinical Trials
optimising clinical development
cancer clinical trials
CRO
CROs
clinical outsourcing
global clinical trials
